C. Carter, C. Allen, and D. Henson, Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases, Cancer, vol.45, issue.1, pp.181-188, 1989.
DOI : 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H

B. Fisher, M. Bauer, and D. Wickerham, Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update, Cancer, vol.152, issue.9, pp.1551-1558, 1983.
DOI : 10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3

A. Goldhirsch, W. Wood, and A. Coates, Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011, Annals of Oncology, vol.22, issue.8, pp.1736-1783, 2011.
DOI : 10.1093/annonc/mdr304

K. Van-zee, D. Manasseh, and J. Bevilacqua, A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy, Annals of Surgical Oncology, vol.20, issue.10, pp.1140-51, 2003.
DOI : 10.1245/ASO.2003.03.015

S. Alran, Y. De-rycke, and V. Fourchotte, Validation and Limitations of Use of a Breast Cancer Nomogram Predicting the Likelihood of Non???Sentinel Node Involvement After Positive Sentinel Node Biopsy, Annals of Surgical Oncology, vol.31, issue.9, pp.2195-201, 2007.
DOI : 10.1245/s10434-006-9331-2

F. Reyal, R. Rouzier, and B. Depont-hazelzet, The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma, PLoS ONE, vol.15, issue.20, p.20297, 2011.
DOI : 10.1371/journal.pone.0020297.t005

P. Freneaux, C. Nos, and A. Vincent-salomon, Histological Detection of Minimal Metastatic Involvement in Axillary Sentinel Nodes: A Rational Basis for a Sensitive Methodology Usable in Daily Practice, Modern Pathology, vol.15, issue.6, pp.641-647, 2002.
DOI : 10.1038/modpathol.3880580

J. Bevilacqua, M. Kattan, and J. Fey, Doctor, What Are My Chances of Having a Positive Sentinel Node? A Validated Nomogram for Risk Estimation, Journal of Clinical Oncology, vol.25, issue.24, pp.3670-3679, 2007.
DOI : 10.1200/JCO.2006.08.8013

G. Viale, S. Zurrida, and E. Maiorano, Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution, Cancer, vol.17, issue.3, pp.492-500, 2005.
DOI : 10.1002/cncr.20809

P. Ravdin, D. Laurentiis, M. Vendely, and T. , Prediction of Axillary Lymph Node Status in Breast Cancer Patients by Use of Prognostic Indicators, JNCI Journal of the National Cancer Institute, vol.86, issue.23, pp.1771-1776, 1994.
DOI : 10.1093/jnci/86.23.1771

P. Gann, S. Colilla, and S. Gapstur, Factors associated with axillary lymph node metastasis from breast carcinoma, Cancer, vol.65, issue.8, pp.1511-1520, 1999.
DOI : 10.1002/(SICI)1097-0142(19991015)86:8<1511::AID-CNCR18>3.0.CO;2-D

S. Crabb, M. Cheang, and S. Leung, Basal Breast Cancer Molecular Subtype Predicts for Lower Incidence of Axillary Lymph Node Metastases in Primary Breast Cancer, Clinical Breast Cancer, vol.8, issue.3, pp.249-56, 2008.
DOI : 10.3816/CBC.2008.n.028

X. Lu, Z. Wang, and J. Iglehart, Predicting features of breast cancer with gene expression patterns, Breast Cancer Research and Treatment, vol.93, issue.12, pp.191-201, 2008.
DOI : 10.1007/s10549-007-9596-6

J. Lee, S. Kim, and Y. Suh, Predictors of Axillary Lymph Node Metastases (ALNM) in a Korean Population with T1-2 Breast Carcinoma: Triple Negative Breast Cancer has a High Incidence of ALNM Irrespective of the Tumor Size, Cancer Research and Treatment, vol.42, issue.1, pp.30-36, 2010.
DOI : 10.4143/crt.2010.42.1.30

B. Van-calster, V. Bempt, I. Drijkoningen, and M. , Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive, Breast Cancer Research and Treatment, vol.64, issue.Suppl1, pp.181-188, 2009.
DOI : 10.1007/s10549-008-9914-7

R. Hwang, S. Krishnamurthy, and K. Hunt, Clinicopathologic Factors Predicting Involvement of Nonsentinel Axillary Nodes in Women With Breast Cancer, Annals of Surgical Oncology, vol.354, issue.3, pp.248-54, 2003.
DOI : 10.1245/ASO.2003.05.020

A. Degnim, C. Reynolds, and G. Pantvaidya, Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram, The American Journal of Surgery, vol.190, issue.4, pp.543-50, 2005.
DOI : 10.1016/j.amjsurg.2005.06.008

A. Pal, E. Provenzano, and S. Duffy, A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive, British Journal of Surgery, vol.12, issue.3, pp.302-311, 2008.
DOI : 10.1002/bjs.5943

H. Kohrt, R. Olshen, and H. Bermas, New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients, BMC Cancer, vol.91, issue.2, p.66, 2008.
DOI : 10.1007/s10549-004-5781-z

E. Barranger, C. Coutant, and A. Flahault, An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement, Breast Cancer Research and Treatment, vol.57, issue.2, pp.113-122, 2005.
DOI : 10.1007/s10549-004-5781-z

R. Saidi, P. Dudrick, and S. Remine, Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer, Am Surg, vol.70, pp.101-106, 2004.

D. Krag, S. Anderson, and T. Julian, Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial, The Lancet Oncology, vol.11, issue.10, pp.927-960, 2010.
DOI : 10.1016/S1470-2045(10)70207-2

A. Giuliano, L. Mccall, and P. Beitsch, Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases, Transactions of the ... Meeting of the American Surgical Association, vol.128, pp.426-458, 2010.
DOI : 10.1097/SLA.0b013e3181f08f32

A. Giuliano, K. Hunt, and K. Ballman, Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis, JAMA, vol.305, issue.6, pp.569-75, 2011.
DOI : 10.1001/jama.2011.90

A. Lucci, L. Mccall, and P. Beitsch, Surgical Complications Associated With Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared With SLND Alone in the American College of Surgeons Oncology Group Trial Z0011, Journal of Clinical Oncology, vol.25, issue.24, pp.3657-63, 2007.
DOI : 10.1200/JCO.2006.07.4062

L. Montgomery, A. Thorne, V. Zee, and K. , Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer, Anesth Analg, vol.95, pp.385-393, 2002.

R. Mansel, L. Fallowfield, and M. Kissin, Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial, JNCI Journal of the National Cancer Institute, vol.98, issue.9, pp.599-609, 2006.
DOI : 10.1093/jnci/djj158

A. Fleissig, L. Fallowfield, and C. Langridge, Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer, Breast Cancer Research and Treatment, vol.72, issue.3, pp.279-93, 2006.
DOI : 10.1007/s10549-005-9025-7

J. Mendez, J. Fey, and H. Cody, Can Sentinel Lymph Node Biopsy Be Omitted in Patients With Favorable Breast Cancer Histology?, Annals of Surgical Oncology, vol.60, issue.1, pp.24-32, 2005.
DOI : 10.1007/s10434-004-1169-x

G. Martelli, R. Miceli, and M. Daidone, Axillary Dissection Versus No Axillary Dissection in Elderly Patients with Breast Cancer and No Palpable Axillary Nodes: Results After 15 Years of Follow-Up, Annals of Surgical Oncology, vol.12, issue.1, pp.125-158, 2011.
DOI : 10.1245/s10434-010-1217-7

C. Rudenstam, D. Zahrieh, and J. Forbes, Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93, J Clin Oncol, vol.24, pp.337-381, 2006.